Welcome to our dedicated page for Guardian Pharmacy Services news (Ticker: GRDN), a resource for investors and traders seeking the latest updates and insights on Guardian Pharmacy Services stock.
Guardian Pharmacy Services, Inc. (NYSE: GRDN) is a long-term care pharmacy services company based in Atlanta, Georgia. This news page aggregates company-issued updates and market-facing announcements so readers can follow how Guardian communicates about its operations, growth, and financial performance over time.
In its public news releases, Guardian highlights its role as one of the nation’s leading long-term care pharmacy services companies, partnering with long-term care facilities to deliver medications and technology-enabled services that are designed to improve adherence to drug regimens and support better clinical outcomes. The company frequently reports on revenue trends, resident counts, and Adjusted EBITDA as part of its quarterly financial results and outlook.
Typical news items for GRDN include quarterly earnings releases, guidance updates, and preliminary financial outlooks, such as reiterations of revenue and Adjusted EBITDA guidance and commentary on expected growth trajectories. Guardian also issues announcements about acquisitions and new pharmacy openings, including transactions that expand its presence into new states or strengthen its footprint in existing regions.
Investors and observers can also find capital markets updates in Guardian’s news, such as information about secondary offerings of Class A common stock, shelf registration statements on Form S-3, and lock-up agreements with pre-IPO stockholders. In addition, the company regularly announces participation in healthcare and investor conferences, where it hosts investor meetings and presentations.
By reviewing the GRDN news feed on this page, readers can track Guardian Pharmacy Services’ reported financial results, expansion activities, and other material communications disclosed through press releases and related announcements.
Guardian Pharmacy Services (NYSE: GRDN) has announced the acquisition of Senior Care Pharmacy in Wichita, Kansas, expanding its long-term care (LTC) pharmacy services footprint in the Midwest. The acquisition strengthens Guardian's presence in south central and southwest Kansas, marking its second pharmacy location in the state alongside its Kansas City operation.
The Wichita location will maintain its existing name, leadership team, and staff, with Michael Counts, president of Guardian's Kansas City pharmacy, overseeing both locations. The acquired pharmacy will benefit from Guardian's local management business model and centralized Corporate Support Team services, including data analytics, HR, IT, and payor relations.
Founded in 2004, Guardian has grown to 52 pharmacies across 38 states through organic expansion, greenfield startups, and acquisitions.
Guardian Pharmacy Services (NYSE: GRDN) reported strong Q1 2025 financial results, with revenue reaching $329.3 million, up 20% year-over-year. The company's resident count increased 15% to 189,000, while net income grew by $2.2 million to $9.3 million. Adjusted EBITDA rose 16% to $23.4 million.
The growth was driven by organic expansion and recent acquisitions, including Heartland Pharmacy and Freedom Pharmacy. Guardian completed another acquisition in Wichita, Kansas on April 1, 2025, bringing its total pharmacy count to 52. The company maintains a strong financial position with $14.0 million in cash and no long-term debt.
Guardian reaffirmed its 2025 guidance, expecting revenue between $1.330-1.350 billion and Adjusted EBITDA of $97-101 million.
Guardian Pharmacy Services (NYSE: GRDN), a leading long-term care pharmacy services provider, has appointed Ashley Stockton as Senior Director, Head of Investor Relations. Stockton brings nearly 30 years of equity markets experience, most recently serving as Head of Southeast Institutional Equity Sales at J.P. Morgan. Her background includes roles in equity research and investment banking.
In her new position, Stockton will lead investor relations strategy and act as the primary liaison with shareholders, analysts, and the investment community. CEO Fred Burke highlighted her extensive background in equity markets and experience advising institutional investors as key qualifications for the role. Stockton holds a BS from the University of Virginia's McIntire School of Commerce and serves on the Georgia Securities Association board.
Guardian Pharmacy Services (NYSE: GRDN), a leading long-term care (LTC) pharmacy services provider in the United States, has scheduled its first quarter 2025 financial results announcement for Monday, May 12, 2025, after market close.
The company will host a conference call at 4:30 pm ET to discuss the quarterly results. Investors and analysts can access the call through:
- Audio webcast: https://investors.guardianpharmacy.com
- U.S. participants dial-in: (646) 564-2877
- International participants dial-in: +1 (800) 549-8228
- Conference ID: "96083"
A replay of the call will be made available shortly after completion and will remain accessible for approximately 60 days.
Guardian Pharmacy Services (NYSE: GRDN) has announced the opening of a new pharmacy location in Columbus, Ohio, expanding its long-term care (LTC) pharmacy services across Ohio, Kentucky, and West Virginia. The new facility, operating as Guardian Pharmacy of Ohio, complements the existing Mullaney's Pharmacy operation in Cincinnati.
The 5,600-square-foot Columbus facility features state-of-the-art technology, automation, and a training center. Since joining Guardian in 2020, Mullaney's Pharmacy has tripled its resident service numbers in less than five years. Tom Mullaney, RPh, will lead both locations alongside Director of Operations Troy Stinson and Joshua Heiden as pharmacist-in-charge.
The expansion strengthens Guardian's presence in the region, serving assisted living, skilled nursing, behavioral health communities, and individuals with intellectual and developmental disabilities. Guardian Pharmacy Services has grown from a single location to 51 pharmacies across 38 states since its founding in 2004.
Guardian Pharmacy Services (NYSE: GRDN) has announced the opening of a new pharmacy in Naples, Florida, expanding its long-term care (LTC) pharmacy services in Southwest Florida. This addition complements their North Port location, enabling better service coverage from Sarasota to Lake Placid to Marco Island.
Guardian Pharmacy of Southwest Florida, established in 2014, has shown significant growth with a 15% annual increase in customer base over the past three years. The Naples location, led by Jay Mandra, PharmD, and Tiffany Fernandez, will enhance service delivery with faster delivery times and improved medication management for LTC communities.
The Naples facility becomes Guardian's eighth pharmacy in Florida, joining locations in Daytona, Jacksonville, Crestview, Orlando, Boca Raton, Tampa, and North Port. Since its founding in 2004, Guardian Pharmacy Services has expanded to 51 pharmacies across 38 states, utilizing a local management business model supported by a centralized Corporate Support Team.
Guardian Pharmacy Services (NYSE: GRDN) reported strong Q4 and full-year 2024 results. Q4 revenue reached $338.6 million, up 20% year-over-year, driven by organic growth and acquisitions of Heartland and Freedom Pharmacy. Resident count grew 14% to 186,000.
Q4 net income decreased to $11.8 million, while Adjusted EBITDA rose 30% to $25.9 million. For full-year 2024, revenue increased 17% to $1.228 billion, though the company recorded a net loss of $71.0 million, primarily due to $131.5 million in share-based compensation expense related to Corporate Reorganization and IPO.
The company ended 2024 debt-free with a $40 million available credit line, expandable to $75 million. For 2025, Guardian projects revenue of $1.330-1.350 billion and Adjusted EBITDA of $97.0-101.0 million, including $4.0 million in public company expenses.
Guardian Pharmacy Services (NYSE: GRDN) has released preliminary Q4 and FY2024 results, reporting strong performance. Q4 revenue reached $338.6 million, up 20.5% year-over-year, while resident count grew 14.1% to 186,000. The growth was driven by organic expansion and acquisitions of Heartland and Freedom Pharmacy.
FY2024 revenue climbed 17.4% to $1.228 billion, though net loss was between $71.8-72.8 million, primarily due to $131.5 million in share-based compensation related to Corporate Reorganization and IPO. Q4 net income is expected between $10.1-11.1 million.
For 2025, Guardian projects revenue of $1.330-1.350 billion and Adjusted EBITDA of $97.0-101.0 million. The company's performance was boosted by increased flu and COVID-19 vaccinations in long-term care facilities.
Guardian Pharmacy Services (NYSE: GRDN), a leading long-term care pharmacy services provider, has announced its participation in the Raymond James & Associates' 46th Annual Institutional Investors Conference. The event will take place in Orlando on March 3, 2025, featuring a company presentation at 9:50am ET.
Investors and interested parties can access the live audio webcast through the company's investor relations website at https://investors.guardianpharmacy.com. A replay of the presentation will be available on the same platform and will remain accessible until Guardian's Q1 2025 earnings release.
Guardian Pharmacy Services (NYSE: GRDN) announced a strategic partnership with Freedom Pharmacy, an independent long-term care pharmacy in Randolph, New Jersey. This marks Guardian's first venture into New Jersey, expanding its Mid-Atlantic footprint. Freedom Pharmacy, founded in 2022, serves over 1,300 residents across North, Northwest and Central New Jersey.
Linda Witzal will continue as president, and all current staff will remain employed, with plans to hire additional employees as the business grows. The partnership allows Freedom to maintain its local focus while accessing Guardian's national resources, including data analytics, HR, IT, and payor relations support.
Guardian Pharmacy Services, founded in 2004, has expanded to 50 pharmacies across 37 states through organic growth, greenfield startups, and acquisitions.